Zobrazeno 1 - 1
of 1
pro vyhledávání: '"G. P. Coffey"'
Autor:
S. Pippig, G. P. Coffey, S. Palmieri, J. Padilla-Eagar, R. Eckert, E. Stefanich, Paul J. Fielder
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 310(3)
Efalizumab (Raptiva) is a humanized CD11a-specific monoclonal antibody that was recently approved for the treatment of moderate to severe psoriasis. In psoriasis patients, the rate of efalizumab clearance from serum is related to T-cell surface expre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4fd35eaa3eabf186c2dd7f820dec38f
https://pubmed.ncbi.nlm.nih.gov/15190122
https://pubmed.ncbi.nlm.nih.gov/15190122
